Veno-venous extracorporeal membrane oxygenation (vv-ECMO) for severe respiratory failure in adult cancer patients: a retrospective multicenter analysis.
16 Feb, 2022 | 08:30h | UTC
Commentary on Twitter
VV #ECMO in adults with cancer developing severe respiratory failure: survival remains poor, no significant advantage, carefully select! Low PLT, elevated lactate, disease status: adverse prognostic factors to be considered as deciding to provide #ECLS.
?️ https://t.co/igatEJH3VS pic.twitter.com/vl7UQKauB0— Intensive Care Medicine (@yourICM) February 12, 2022